Registro:

Referencias:

• Sidwell, R.W., Smee, D.F., Viruses of the Bunya and Togaviridae families: Potential as bioterrorism agents and means of control (2003) Antiviral Res., 57, pp. 101-111
• Damonte, E.B., Pujol, C.A., Coto, C.E., Prospects for the therapy and prevention of dengue virus infections (2004) Adv. Virus Res., 63, pp. 239-285
• Tseng, C.K., Overview of antiviral drug discovery and development (2005) Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats, , Torrence PF (Ed.). John Wiley & Sons, New Jersey, USA 31-82
• Leyssen, P., De Clercq, E., Neyts, J., Molecular strategies to inhibit the replication of RNA viruses (2008) Antiviral Res., 78, pp. 9-25
• Rotz, L.D., Khan, A.S., Lillibridge, S.R., Ostroff, S.M., Hughes, J.M., Public health assessment of potential biological terrorism agents (2002) Emerging Infect. Dis., 8, pp. 225-230
• Borio, L., Inglesby, T., Peters, C.J., Hemorrhagic fever viruses as biological weapons. Medical and public health management (2002) JAMA, 287, pp. 2391-2405
• Delgado, S., Erickson, B.R., Agudo, R., Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia (2008) PLoS Pathog., 4, pp. e1000047
• Briese, T., Paweska, J.T., McMullan, L.K., Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from Southern Africa (2009) PLoS Pathog., 5, pp. e1000455
• Salvato, M.S., Jcs, C., Buchmeier, M.J., Family Arenaviridae (2010) Virus Taxonomy. Ninth Report of the International Committee on Taxonomy of Viruses, , Van Regenmortel MHV, King A, Mayo MA, Maniloff J, Desselberger U, Ball LA (Eds) Elsevier Academic Press, London, UK In Press
• McCormick, J.B., Fisher-Hoch, S.P., Lassa fever (2002) Curr. Top. Microbiol. Immunol., 262, pp. 75-109
• Howard, C.R., Antigenic diversity among the arenaviruses (1993) The Arenaviridae, , Salvato MS (Ed.). Plenum Press, New York, USA 37-49
• Salazar-Bravo, J., Ruedas, L.A., Yates, T.L., Mammalian reservoirs of arenaviruses (2002) Curr. Top. Microbiol. Immunol., 262, pp. 25-63
• Bowen, M.D., Peters, C.J., Nichol, S.T., The phylogeny of New World (Tacaribe Complex) arenaviruses (1996) Virology, 219, pp. 285-290
• Charrel, R.N., De Lamballerie, X., Emonet, S., Phylogeny of the genus Arenavirus (2008) Curr. Opin. Microbiol., 11, pp. 362-368
• Charrel, R.N., Feldmann, H., Fulhorst, C.F., Khelifa, R., De Chese, R., De Lamballerie, X., Phylogeny of New World arenaviruses based on the complete conding sequences of the small genomic segment identifed an evolutionary lineage produced by intrasegmental recombination (2002) Biochem. Biophys. Res. Commun., 296, pp. 1118-1124
• Archer, A.A., Rico-Hesse, R., High genetic divergence and recombination in arenaviruses from the Americas (2002) Virology, 304, pp. 274-281
• Mnb, C., Milazzo, M.L., Bradley, R.D., Fulhorst, C.F., Catarina virus, an arenaviral species principally associated with Neotoma micropus (Southern plains woodrat) in Texas (2007) Am. J. Trop. Med. Hyg., 77, pp. 732-736
• Mnb, C., Milazzo, M.L., Borchert, J.N., Abbott, K.D., Bradley, R.D., Fulhorst, C.F., Diversity among Tacaribe serocomplex viruses (family Arenaviridae) naturally associated with the Mexican woodrat (Neotoma mexicana) (2008) Virus Res., 133, pp. 211-217
• Milazzo, M.L., Mnb, C., Haynie, M.L., Abbott, K.D., Bradley, R.D., Fulhorst, C.F., Diversity among Tacaribe serocomplex viruses (family Arenaviridae) naturally associated with the white-throated woodrat (Neotoma albigula) in the Southwestern United States (2008) Vector Borne Zoonotic Dis., 8, pp. 523-540
• Lecompte, E., Ter Meulen, J., Emonet, S., Daffs, S., Charrel, R.N., Genetic identifcation of Kodoko virus, a novel arenavirus of the African pigmy mouse (Mus Nannomys minutoides) in West Africa (2007) Virology, 364, pp. 178-183
• Vieth, S., Drosten, C., Lenz, O., RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene (2007) Trans. R. Soc. Trop. Med. Hyg., 101, pp. 1253-1264
• Gunther, S., Hoofd, G., Charrel, R., Mopeia virus-related arenavirus in Natal miltimammate mice, Morogoro, Tanzania (2009) Emerg. Infect. Dis., 15, pp. 2008-2012
• Palacios, G., Savji, N., Hui, J., Genomic and phylogenetic characterization of Merino Walk virus, a novel arenavirus isolated in South Africa (2010) J. Gen. Virol., 91, pp. 1315-1324
• Lozano, M.E., Posik, D.M., Albariño, C.G., Characterization of arenaviruses using a family-specifc primer set for RT-PCR amplifcation and RFLP analyses. Its potential use for detection of uncharacterized arenaviruses (1997) Virus Res., 49, pp. 79-89
• Palacios, G., Druce, J., Du, L., A new arenavirus in a cluster of fatal transplant-associated diseases (2008) N. Engl. J. Med., 358, pp. 991-998
• Charrel, R.N., De Lamballerie, X., Zoonotic aspects of arenavirus infections (2010) Vet. Microbiol., 140, pp. 213-220
• MacHer, A.M., Wolfe, M.S., Historical Lassa fever reports and 30-year clinical update (2006) Emerg. Infect. Dis., 12, pp. 835-836
• Kitching, A., Addiman, S., Cathcart, S., A fatal case of Lassa fever in London, January 2009 (2009) Euro Surveill., 14 (6). , pii 19117
• Atkin, S., Anaraki, S., Gothard, P., The frst case of Lassa fever imported from Mali to the United Kingdom, February 2009 (2009) Euro Surveill., 14 (10). , pii 19145
• Drosten, C., Kümerer, B.M., Schmitz, H., Günther, S., Molecular diagnostics of viral hemorrhagic fevers (2003) Antiviral Res., 57, pp. 61-87
• Richmond, J.K., Baglole, D.J., Lassa fever: Epidemiology, clinical features, and social consequences (2003) BMJ, 327, pp. 1271-1275
• Lecompte, E., Daffs, F.E., Mastomys natalensis and Lassa fever, West Africa (2006) Emerg. Infect. Dis., 12, pp. 1971-1974
• Kernéis, S., Koivogui, L., Magassouba, N., Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: A cross-sectional study (2009) PLoS Negl. Trop. Dis., 3, pp. E548
• Peters, C.J., Human infection with arenavirus in the Americas (2002) Curr. Top. Microbiol. Immunol., 262, pp. 65-74
• Cummins, D., McCormick, J.B., Bennett, D., Acute sensorineural deafness in Lassa fever (1990) JAMA, 264, pp. 2093-2096
• Enria, D.A., Briggiler, A.M., Sánchez, Z., Treatment of Argentine hemorrhagic fever (2008) Antiviral Res., 78, pp. 132-139
• Barton, L.L., Mets, M.B., Congenital lymphocytic choriomeningitis virus infection: Decade of rediscovery (2001) Clin. Infect. Dis., 33, pp. 370-374
• Jamieson, D.J., Kourtis, A.P., Bell, M., Rasmussen, S.A., Lymphocytic choriomeningitis virus: And emerging obstetric pathogen? (2006) Am. J. Obst. Gynecol., 194, pp. 1532-1536
• Fisher, S.A., Graham, M.B., Kuehnert, M.J., Transmission of lymphocytic choriomeningiris virus by organ transplantation (2006) N. Engl. J. Med., 354, pp. 2235-2249
• Maiztegui, J.I., McKee Jr., K.T., Barrera Oro, J.G., Protective effcacy of a live attenuated vaccine against Argentina hemorrhagic fever (1998) J. Infect. Dis., 177, pp. 277-283
• Enría, D.A., Barerra Oro, J.G., Junin virus vaccines (2002) Curr. Top. Microbiol. Immunol., 263, pp. 239-264
• Geisbert, T.W., Jones, S., Fritz, E.A., Development of a new vaccine for the prevention of Lassa fever (2005) PLoS Med., 2, pp. E183
• Lukashevich, I.S., Carrion Jr., R., Salvato, M.S., Safety, immunogenicity, and effcacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates (2008) Vaccine, 26, pp. 5246-5254
• Bredenbeck, P.J., Molenkamp, R., Span, W.J., A recombinant yellow fever 17D vaccine expressing Lassa virus glycoproteins (2006) Virology, 345, pp. 299-304
• McCormick, J.B., King, I.J., Webb, P.A., Lassa fever. Effective therapy with ribavirin (1986) N. Engl. J. Med., 314, pp. 20-26
• Crowcroft, N.S., Management of Lassa fever in European countries (2002) Eur. Surveill., 7, pp. 50-52
• Haas, W.H., Breuer, T., Pfaff, G., Imported Lassa fever in Germany: Surveillance and management of contact persons (2003) Clin. Infect. Dis., 36, pp. 1254-1258
• Bossi, P., Tegnell, A., Baka, A., Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses (2004) Euro. Surveill., 9, pp. E11-E12
• Fisher-Hoch, S.P., Gborie, S., Parker, L., Huggins, J., Unexpected adverse reactions during a clinical trial in rural West Africa (1992) Antiviral Res., 19, pp. 139-147
• Enria, D.A., Maiztegui, J.I., Antiviral treatment of Argentine hemorrhagic fever (1994) Antiviral Res., 23, pp. 23-31
• Graci, J.D., Cameron, C.E., Mechanisms of action of ribavirin against distinct viruses (2006) Rev. Med. Virol., 16, pp. 37-48
• Streeter, D.G., Witkowski, J.T., Khare, G.P., Mechanism of action of 1-b-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent (1973) Proc. Natl Acad. Sci. USA, 70, pp. 1174-1178
• Ruiz-Jarabo, C.M., Ly, C., Domingo, E., De La Torre, J.C., Lethal mutagenesis of the prototype arenavirus lymphocytic choriomeningitis virus (LCMV) (2003) Virology, 308, pp. 37-47
• York, J., Romanowski, V., Lu, M., Nunberg, J.H., The signal peptide of the JUNV arenavirus envelope glycoprotein is myristoilated and forms an essential subunit of the mature G1-G2 complex (2004) J. Virol., 78, pp. 10783-10792
• Cao, W., Henry, M.D., Borrow, P., Identifcation of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus (1998) Science, 282, pp. 2079-2081
• Spiropoulou, C.F., Kunz, S., Rollin, P.E., Campbell, K.P., Oldstone, M.B., New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor (2002) J. Virol., 76, pp. 5140-5146
• Kunz, S., Rojek, J.M., Perez, M., Spiropoulou, C.F., Oldstone, M.B., Characterization of the interaction of Lassa fever virus with its cellular receptor a-dystroglycan (2005) J. Virol., 79, pp. 5979-5987
• Radoshitzky, S.R., Abraham, J., Spiropoulou, C.F., Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses (2007) Nature, 446, pp. 92-96
• Abraham, J., Corbett, K.D., Farzan, M., Choe, H., Harrison, S.C., Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses (2010) Nat. Struct. Mol. Biol., 17, pp. 438-444
• Flanagan, M.L., Oldenburg, J., Reignier, T., New World Clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1 (2008) J. Virol., 82, pp. 938-948
• Reignier, T., Oldenburg, J., Flanagan, M.L., Hamilton, G.A., Martin, V.K., Cannon, P.M., Receptor use by the Whitewater Arroyo virus glycoprotein (2008) Virology, 371, pp. 439-446
• Rojek, J.M., Kunz, S., Cell entry by human pathogenic arenaviruses (2008) Cell. Microbiol., 10, pp. 828-835
• Castilla, V., Mersich, S.E., Candurra, N.A., Damonte, E.B., The entry of Junin virus into Vero cells (1994) Arch. Virol., 136, pp. 363-374
• Di Simone, C., Zandonatti, M.A., Buchmeier, M.J., Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike (1994) Virology, 198, pp. 455-465
• York, J., Nunberg, J.H., Role of the stable signal peptide of Junin arenavirus envelope glycoprotein in pH-dependent membrane fusion (2006) J. Virol., 80, pp. 7775-7780
• Martínez, M.G., Cordo, S.M., Candurra, N.A., Characterization of Junin arenavirus cell entry (2007) J. Gen. Virol., 88, pp. 1776-1784
• Martínez, M.G., Cordo, S.M., Candurra, N.A., Involvement of cytoskeleton on Junin virus entry (2008) Virus Res., 138, pp. 17-25
• Rojek, J.M., Perez, M., Kunz, S., Cellular entry of lymphocytic choriomeningitis virus (2008) J. Virol., 82, pp. 1505-1517
• Rojek, J.M., Sanchez, A.B., Nguyen, N.T., De La Torre, J.C., Kunz, S., Different mechanism of cell entry by human-pathogenic Old World and New World arenaviruses (2008) J. Virol., 82, pp. 7677-7687
• Quirin, K., Eschli, B., Scheu, I., Poort, L., Kartenbeck, J., Helenius, A., Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes (2008) Virology, 378, pp. 21-33
• Tortorici, M.A., Albariño, C.G., Posik, D.M., Arenavirus nucleocapsid protein displays a transcriptional antitermination activity in vivo (2001) Virus Res., 73, pp. 41-55
• López, N.M., Franze-Fernández, M.T., A single stem-loop structure in Tacaribe arenavirus intergenic region is essential for transcription termination but is not required for a correct initiation of transcription and replication (2007) Virus Res., 124, pp. 237-244
• Beyer, W.R., Popplau, D., Garten, W., Von Laer, D., Lenz, O., Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P (2003) J. Virol., 77, pp. 2866-2872
• Kunz, S., Edelmann, K.H., De La Torre, J.C., Gorney, R., Mba, O., Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions (2003) Virology, 314, pp. 168-178
• Agnihothram, S.S., York, J., Nunberg, J.H., Role of the stable signal peptide and cytoplasmic domain of G2 in regulating intracellular transport of the Junín virus envelope glycoprotein complex (2006) J. Virol., 80, pp. 5189-5198
• Strecker, T., Eichler, R., Ter Meulen, J., Lassa virus Z protein is a matrix protein and suffcient for the release of virus-like particles (2003) J. Virol., 77 (19), pp. 10700-10705
• Urata, S., Noda, T., Kawaoka, Y., Yokosawa, H., Yasuda, J., Cellular factors required for Lassa virus budding (2006) J. Virol., 80, pp. 4191-4195
• Capul, A.A., Perez, M., Burke, E., Kunz, Z., Buchmeier, M.J., De La Torre, J.C., Arenavirus Z-glycoprotein association requires Z myristoylation but not functional RING or late domains (2007) J. Virol., 81, pp. 9451-9460
• Lee, A.M., Rojek, J.M., Gundersen, A.T., Inhibition of cellular entry of lynphocytic choriomeningitis virus by amphipathic DNA polymers (2008) Virology, 372, pp. 107-117
• Bolken, T.C., Laquerre, S., Zhang, Y., Identifcation and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenavirus (2006) Antiviral Res., 69, pp. 86-97
• Larson, R.A., Dai, D., Hosack, V.T., Identifcation of a broad-spectrum arenavirus entry inhibitor (2008) J. Virol., 82, pp. 10768-10775
• York, J., Dai, D., Amberg, S., Nunberg, J.H., PH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors (2008) J. Virol., 82, pp. 10932-10939
• Lee, A.M., Rojek, J.M., Spiropoulou, C.F., Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses (2008) J. Biol. Chem., 283, pp. 18734-18742
• Whitby, L.R., Lee, A.M., Kunz, S., Mba, O., Boger, D.L., Characterization of Lassa virus cell entry inhibitors: Determination of the active enantiomer by asymmetric synthesis (2009) Bioorg. Med. Chem. Lett., 19, pp. 3771-3774
• Vaillant, A., Juteau, J.M., Lu, H., Phosphorothioate oligonucleotides inhibit human immunodefciency virus type 1 fusion by blocking gp41 core formation (2006) Antimicrob. Agents Chemother., 50, pp. 1393-1401
• Wolf, M.C., Freiberg, A.N., Zhang, T., A broad-spectrum antiviral targeting entry of enveloped viruses (2010) Proc. Natl Acad. Sci. USA, 107, pp. 3157-3162
• York, J., Berry, J.D., Ströher, U., An antibody directed against the fusion peptide of Junín virus envelope glycoprotein GPC inhibits pH-induced membrane fusion (2010) J. Virol., 84, pp. 6119-6129
• Cornu, T.I., De La Torre, J.C., RING finger Z protein of Lymphocytic Choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome (2001) J. Virol., 75, pp. 9415-9426
• Cornu, T.I., De La Torre, J.C., Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis (2002) J. Virol., 76, pp. 6678-6688
• López, N., Jácamo, R., Franze-Fernández, M.T., Transcription and RNA replication of Tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor on these processes (2001) J. Virol., 75, pp. 12241-12251
• Jácamo, R., López, N., Wilda, M., Franze-Fernández, M.T., Tacaribe virus Z protein interacts with the L polymerase protein to inhibit viral RNA synthesis (2003) J. Virol., 7 (7), pp. 10383-10393
• Perez, M., Craven, R.C., De La Torre, J.C., The small RING finger protein Z drives arenavirus budding: Implications for antiviral strategies (2003) Proc. Natl Acad. Sci. USA, 100, pp. 12978-12983
• Neuman, B.W., Adair, B.D., Burns, J.W., Milligan, R.A., Buchmeier, M.J., Yeager, M., Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image ana lysis (2005) J. Virol., 79, pp. 3822-3830
• Schlie, K., Maisa, A., Freiberg, F., Groseth, A., Strecker, T., Garten, W., Viral protein determinants of Lassa virus entry and release from polarized epithelial cells (2010) J. Virol., 84, pp. 3178-3188
• Eichler, R., Strecker, T., Kolesnikova, L., Characterization of the Lassa virus matrix protein Z: Electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP) (2004) Virus Res., 100, pp. 249-255
• Shtanko, O., Imai, M., Goto, H., A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles (2010) J. Virol., 84, pp. 5415-5422
• Klb, B., Campbell Dwyer, E.J., Carlile, G.W., Djavani, M., Salvato, M.S., Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins (1998) J. Virol., 72, pp. 3819-3826
• Klb, B., Campbell Dwyer, E.J., Salvato, M.S., An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm (1998) J. Virol., 72, pp. 758-766
• Campbell Dwyer, E.J., Lai, H., MacDonald, R.C., Salvato, M.S., Klb, B., The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner (2000) J. Virol., 74, pp. 3293-3300
• Djavani, M., Topisirovic, I., Zapata, J.C., The proline-rich homeodomain (PRH/ HEX) protein is downregulated in liver during infection with lymphocytic choriomeningitis virus (2005) J. Virol., 79, pp. 2461-2473
• Casabona, J.C., Levingston Mac Leod, J.M., Loureiro, M.E., Gómez, G.A., López, N., The RING domain and the residue L79 of the Z protein are involved in both the rescue of nucleocapsids and the incorporation of glycoproteins into infectious chimeric arenavirus-like particles (2009) J. Virol., 83, pp. 7029-7039
• Volpon, L., Osborne, M.J., Capul, A.A., De La Torre, C., Klb, B., Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E (2010) Proc. Natl Acad. Sci. USA, 107, pp. 5441-5446
• Rice, W.G., Turpin, J.A., Schaeffer, C.A., Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifes novel HIV-1 zinc finger inhibitors (1996) J. Med. Chem., 39, pp. 3606-3616
• Tummino, P.J., Harvey, P.J., McQuade, T., The human immunodefciency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfde benzamides and benzisothiazolones: Correlation with anti-HIV and virucidal activities (1997) Antimicrob. Agents Chemother., 41, pp. 394-400
• García, C.C., Candurra, N.A., Damonte, E.B., Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds (2000) Antivir. Chem. Chemother., 11, pp. 231-237
• García, C.C., Candurra, N.A., Damonte, E.B., Mode of inactivation of arenaviruses by disulfde-based compounds (2002) Antiviral Res., 55, pp. 437-446
• García, C.C., Candurra, N.A., Damonte, E.B., Differential inhibitory action of two azoic compounds against arenaviruses (2003) Int. J. Antimicrob. Agents, 21, pp. 319-324
• García, C.C., Ellenberg, P.C., Artuso, M.C., Scolaro, L.A., Damonte, E.B., Characterization of Junín virus particles inactivated by a zinc finger-reactive compound (2009) Virus Res., 143, pp. 106-113
• García, C.C., Djavani, M., Topisirovic, I., Borden, K.L., Salvato, M.S., Damonte, E.B., Arenavirus Z protein as an antiviral target: Virus inactivation and protein oligomerization by zinc finger-reactive compounds (2006) J. Gen. Virol., 87, pp. 1217-1228
• Sepúlveda, C.S., García, C.C., Damonte, E.B., Inhibition of arenavirus infection by thiuram and aromatic disulfdes (2010) Antiviral Res., 87 (3), pp. 329-337
• Andrei, G., De Clercq, E., Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro (1990) Antiviral Res., 14, pp. 287-300
• Andrei, G., De Clercq, E., Molecular approaches for the treatment of hemorrhagic fever virus infections (1993) Antiviral Res., 22, pp. 45-75
• Gunther, S., Asper, M., Röser, C., Application of real-time PCR for testing antiviral compounds against Lassa virus SARS coronavirus and Ebola virus in vitro (2004) Antiviral Res., 63, pp. 209-215
• Sepúlveda, C.S., Fascio, M.L., Mazzucco, M.B., Synthesis and evaluation of N-substituted acridones as antiviral agents against hemorrhagic fever viruses (2008) Antiviral Chem. Chemother., 19, pp. 41-47
• Gowen, B.B., Wong, M.H., Jung, K.H., In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections (2007) Antimicrob. Agents Chemother., 51, pp. 3168-3176
• Furuta, Y., Takahashi, K., Fukuda, Y., In vitro and in vivo activities of anti-infuenza virus compound T-705 (2002) Antimicrob. Agents Chemother., 46, pp. 977-981
• Takahashi, K., Furuta, Y., Fukuda, Y., In vitro and in vivo activities of T-705 and oseltamivir against infuenza virus (2003) Antivir. Chem. Chemother., 14, pp. 235-241
• Sidwell, R.W., Barnard, D.L., Day, C.W., Effcacy of orally administered T-705 on lethal avian Infuenza A (H5N1) virus infections in mice (2007) Antimicrob. Agents. Chemother., 51, pp. 845-851
• Furuta, Y., Takahashi, K., Shiraki, K., T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections (2009) Antiviral Res., 82, pp. 95-102
• Gowen, B.B., Smee, D.F., Wong, M.-H., Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 effcacy and reduced toxicity suggests an alternative to ribavirin (2008) PLoS One, 3, pp. e3725
• Martín, V., Abia, D., Domingo, E., Grande-Pérez, A., An interfering activity against lymphocytic choriomeningitis virus replication associated with enhanced mutagenesis (2010) J. Gen. Virol., 91, pp. 990-1003
• Wachsman, M.B., Emf, L., Ramírez, J.A., Galagovsky, L.R., Coto, C.E., Antiviral effect of brassinosteroids against herpes virus and arenavirus (2000) Antivir. Chem. Chemother., 11, pp. 71-77
• Castilla, V., Larzábal, M., Aguirre Sgalippa, N., Wachsman, M.B., Coto, C.E., Antiviral mode of action of a synthetic brassinosteroid against Junín virus replication (2005) Antiviral Res., 68, pp. 88-95
• Acosta, E.G., Bruttomesso, A.C., Bisceglia, J.A., Wachsman, M.B., Galagovsky, L.R., Castilla, V., Dehydroepiandrosterone, epiandrosterone and synthetic derivatives inhibit Junín virus replication in vitro (2008) Virus Res., 135, pp. 203-212
• Barradas, J.S., Errea, M.I., D'Accorso, N.B., Sepúlveda, C.S., Talarico, L.B., Damonte, E.B., Synthesis and antiviral activity of azoles obtained from carbohydrates (2008) Carbohydr. Res., 343, pp. 2468-2474
• Sanchez, A.B., Perez, M., Cornu, T.I., De La Torre, J.C., RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus (2005) J. Virol., 79, pp. 11071-11081
• Müller, S., Günther, S., Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus (2007) Antimicrob. Agents Chemother., 51, pp. 2215-2218
• Artuso, M.C., Ellenberg, P.C., Scolaro, L.A., Damonte, E.B., García, C.C., Inhibition of Junín virus replication by small interfering RNAs (2009) Antiviral Res., 84, pp. 31-37
• Candurra, N.A., Damonte, E.B., Effect of inhibitors of the intracellular exocytic pathway on glycoprotein processing and maturation of Junin virus (1997) Arch. Virol., 142, pp. 2179-2193
• Damonte, E.B., Mersich, S.E., Candurra, N.A., Intracellular processing and transport of Junin virus glycoproteins infuences virion infectivity (1994) Virus Res., 34, pp. 317-326
• Hruby, D.E., Franke, C.A., Viral acylproteins: Greasing the wheels of assembly (1993) Trends Microbiol., 1, pp. 20-25
• Boutin, J.A., Myristoylation (1997) Cell Signal., 9, pp. 15-35
• Towler, D.A., Gordon, J.I., Adams, S.P., Glaser, L., The biology and enzymology of eukaryotic protein acylation (1988) Ann. Rev. Biochem., 57, pp. 69-99
• Parang, K., Wiebe Jr., L.I., Knaus, E.E., Huang, J.S., Tyrrell, D.L., Czismadia, F., In vitro antiviral activities of myristic acid analogs against human immunodefciency and hepatitis B viruses (1997) Antiviral Res., 34, pp. 75-90
• Cordo, S.M., Candurra, N.A., Damonte, E.B., Myristic acid analogs are inhibitors of Junin virus replication (1999) Microbes Infect., 1, pp. 609-614
• Perez, M., Greenwald, D.L., De La Torre, J.C., Myristoylation of the RING finger Z protein is essential for arenavirus budding (2004) J Virol., 78, pp. 11443-11448
• Lenz, O., Ter Meulen, J., Klenk, H.D., Seidah, N.G., Garten, W., The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P (2001) Proc. Natl Acad. Sci. USA, 98, pp. 12701-12705
• Eichler, R., Lenz, O., Garten, W., Strecker, T., The role of single N-glycans in proteolytic processing and cell surface transport of the Lassa virus glycoprotein GP-C (2006) Virol. J., 3, p. 41
• Pullikotil, P., Vincent, M., Nichol, S., Seidah, N., Development of protein-based inhibitors of the proprotein of convertase SKI-1/S1P: Processing of SREBP-2, ATF6, and a viral glycoprotein (2004) J. Biol. Chem., 279, pp. 17338-17347
• Maisa, A., Ströher, U., Klenk, H.D., Garten, W., Strecker, T., Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants (2009) PLoS Negl. Trop. Dis., 3, pp. E446
• Rojek, J.M., Pasqual, G., Sanchez, A.B., Nguyen, N.T., De La Torre, J.C., Kunz, S., Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses (2010) J. Virol., 84, pp. 573-584
• Rojek, J.M., Lee, A.M., Nguyen, N., Spiropoulou, C.F., Kunz, S., Site 1 protease is required for proteolytic processing of the glycoproteins of the South American hemorrhagic fever viruses Junin Machupo and Guanarito (2008) J. Virol., 82, pp. 6045-6051
• Bergeron, E., Vincent, M.J., Nichol, S.T., Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity (2007) J. Virol., 81, pp. 13271-13276
• Basak, S., Mohottalage, D., Basak, A., Multibranch and pseudopeptide approach for design of novel inhibitors of subtilisin kexin isozyme-1 (2006) Protein Pept. Lett., 13, pp. 863-876
• Bodvard, K., Mohlin, J., Knecht, W., Recombinant expression, purifcation, and kinetic and inhibitor characterisation of human site-1-protease (2007) Protein Expr. Purif., 51, pp. 308-319
• Raulin, J., Lipids and retroviruses (2000) Lipids, 35, pp. 123-130
• Bartolotta, S., García, C.C., Candurra, N.A., Damonte, E.B., Effect of fatty acids on arenavirus replication: Inhibition of virus production by lauric acid (2001) Arch. Virol., 146, pp. 777-790
• Williamson, P., Schlegel, R.A., Back and forth: The regulation and function of transbilayer phospholipid movement in eukaryotic cells (1994) Mol. Membr. Biol., 11, pp. 199-216
• Zwaal, R.F., Schroit, A.J., Pathophysiologic implications of membrane phospholipid asymmetry in blood cells (1997) Blood, 89, pp. 1121-1132
• Seigneuret, M., Devaux, P.F., ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: Relation to shape changes (1984) Proc. Natl Acad. Sci. USA, 81, pp. 3751-3755
• Soares, M.M., King, S.W., Thorpe, P.E., Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases (2008) Nat. Med., 14, pp. 1357-1362
• Shah, W.A., Peng, H., Carbonetto, S., Role of non-raft cholesterol in lymphocytic choriomeningitis virus infection via a-dystroglycan (2006) J. Gen. Virol., 87, pp. 673-678
• Schlie, K., Maisa, A., Lennartz, F., Ströher, U., Garten, W., Strecker, T., Characterization of Lassa virus glycoprotein oligomerization and infuence of cholesterol on virus replication (2010) J. Virol., 84, pp. 983-992
• Montoya, C., Jaimes, F., Higuita, E., Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (the LIVE study): A Phase-II randomized clinical trial (2009) Trials, 10, p. 41
• Badera, T., Korbab, B., Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro (2010) Antiviral Res., 86, pp. 241-245
• Sjd, N., Zang, T., Bieniasz, P.D., Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu (2008) Nature, 451, pp. 425-430
• Ishikawa, J., Kaisho, T., Tomizawa, H., Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth (1995) Genomics, 26, pp. 527-534
• Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., Banting, G., Bst-2/ HM1.24 is a raft-associated apical membrane protein with an unusual topology (2003) Traffc, 4, pp. 694-709
• Van Damme, N., Goff, D., Katsura, C., The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein (2008) Cell Host Microbe, 3, pp. 245-252
• Sakuma, T., Noda, T., Urata, S., Kawaoka, Y., Yasuda, J., Inhibition of Lassa and Marburg virus production by tetherin (2009) J. Virol., 83, pp. 2382-2385
• Radoshitzky, S.R., Dong, L., Chi, X., Infectious Lassa virus, but not floviruses, is restricted by bst-2/tetherin (2010) J. Virol., , DOI:10.1128/JVI.00103-10 Epub ahead of print
• Garrus, J.E., Von Schwedler, U.K., Pornillos, O.W., Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding (2001) Cell, 107, pp. 55-65
• Martin-Serrano, J., Zang, T., Bieniasz, P.D., HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress (2001) Nat. Med., 7, pp. 1313-1319
• Freed, E.O., Viral late domains (2002) J. Virol., 76, pp. 4679-4687
• Carter, C.A., Tsg101: HIV-1's ticket to ride (2002) Trends Microbiol., 10, pp. 203-205
• Capul, A., De La Torre, J.C., A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding (2008) Virology, 382, pp. 107-114
• Cooray, S., The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival (2004) J. Gen. Virol., 85, pp. 1065-1076
• Buchkovich, N.J., Yu, Y., Zampieri, C.A., Alwine, J.C., The TORrid affairs of viruses: Effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway (2008) Nat. Rev. Microbiol., 6, pp. 266-275
• Linero, F.N., Scolaro, L.A., Participation of the phosphatidylinositol 3-kinase/Akt pathway in Junín virus replication in vitro (2009) Virus Res., 145, pp. 166-170
• Bowick, G., Fennewald, S., Scott, E., Identifcation of differentially activated cell-signalling networks associated with Pichinde virus pathogenesis by using systems kinomics (2007) J. Virol., 81, pp. 1923-1933
• Vela, E.M., Bowick, G.C., Herzog, N.K., Aronson, J.F., Genistein treatment of cells inhibits arenavirus infection (2008) Antiviral Res., 77, pp. 153-156

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------